Loading…
AstraZeneca Pharma India (ASTRAZEN)₹6,515+0.54%Pharmaceuticals
At the end of the Jun 2026 quarter, AstraZeneca Pharma India's shareholders were: promoters 75.06%, FIIs 2.67%, DIIs 6.05%, public 16.22%. Promoter holding is unchanged on the quarter. FII holding is down 0.35 percentage points from 3.02% a year earlier. 0.00% of promoter shares were pledged. It had 29,336 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 75.06% | 75.06% | 75.06% | 75.06% | 75.06% | 75.06% | 75.06% | 75.06% | 75.06% | 75.06% | 75.06% | 75.06% |
| FIIs | 2.68% | 2.65% | 2.72% | 2.78% | 2.89% | 2.91% | 2.88% | 3.02% | 2.73% | 2.70% | 2.77% | 2.67% |
| DIIs | 2.41% | 2.75% | 3.75% | 4.96% | 5.05% | 5.18% | 4.62% | 4.53% | 5.23% | 5.52% | 5.76% | 6.05% |
| Public | 19.85% | 19.54% | 18.47% | 17.20% | 17.00% | 16.85% | 17.44% | 17.39% | 16.98% | 16.72% | 16.41% | 16.22% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 32,378 | 29,030 | 29,416 | 27,167 | 27,613 | 27,320 | 32,464 | 34,376 | 32,912 | 31,549 | 29,005 | 29,336 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| AstraZeneca Pharmaceuticals AB | Promoter | 75.01% | 0.00 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund(Various Schemes) | DII | 2.92% | 0.00 |
| Tejas Bhalchandra Trivedi | Public | 2.67% | 0.00 |
| Shivani Tejas Trivedi | Public | 2.32% | −0.07 |
| Icici Prudential - Various Schemes | DII | 1.38% | +0.27 |
| Bandhan - Various Schemes | DII | 1.29% | +0.15 |
| Prashant Jain | Public | 1.11% | 0.00 |
Promoters held 75.06% of AstraZeneca Pharma India at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 2.67% (down 0.10 percentage points from 2.77% a quarter earlier) and domestic institutions (DIIs) held 6.05% (up 0.29 percentage points from 5.76% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
AstraZeneca Pharma India had 29,336 shareholders at the end of the Jun 2026 quarter, against 34,376 a year earlier.
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund(Various Schemes) (DII) held 2.92% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.